PRR29-AS1

Across TCGA pan-cancer cohorts, PRR29-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated PRR29-AS1 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher PRR29-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PRR29-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and BLCA show a favorable association.

BRCA, BLCA, and READ are the cancer types where PRR29-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.538	0.298	<.001	68	view →
BLCA	OS	Quartile	IV	0.730	0.442	.002	57	view →
READ	DFS	Median	All	0.720	0.894	.001	38	view →
LUSC	DFS	Quartile	II,III,IV	0.257	0.533	.002	28	view →
KIRC	DFS	Median	All	0.733	0.512	.002	21	view →
THYM	DFS	Quartile	All	1.000	0.794	.003	21	view →
CESC	DFS	Tertile	IV	0.620	0.265	.025	18	view →
PAAD	DFS	Median	All	0.362	0.210	.014	16	view →
UVM	OS	Median	All	0.393	0.844	.001	15	view →
KIRP	OS	Quartile	II,III,IV	0.856	0.555	.021	14	view →
SKCM	DFS	Tertile	All	0.695	0.568	.020	13	view →
ACC	DFS	Tertile	All	0.282	0.597	.015	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

PRR29-AS1–BRCA (DFS)

Open the BRCA breakdown →